VANCOUVER, BC, Feb. 10, 2021 /CNW/ - (TSXV: OGN) Orogen
Royalties Inc. ("Orogen" or the "Company") is pleased to announce
that Mr. J. Patrick Nicol, the
Company's current President and Chief Executive Officer, has been
appointed to the Board of Directors.
Orogen is also pleased to announce that Cranberry Capital Inc.,
an investment company controlled by Mr. Paul van Eeden, Chairman of the Board of
Directors, has agreed to an investment of $2.7 million in the Company. Upon the closing of
the private placement, Mr. van Eeden will be the beneficial owner
of approximately 14.9% of the Company on a partially diluted
basis.
Cranberry Capital will subscribe for 10,000,000 units (the
"Units") at a price of $0.27 per
Unit. Each Unit consists of one common share of the Company and one
share purchase warrant (the "Warrants"). Each Warrant is
exercisable into one common share of the Company at a price of
$0.40 for period of five years. No
commissions or fees will be paid in connection with the private
placement.
Cranberry Capital's investment is considered a related party
transaction within the meaning of Multilateral Instrument 61-101 –
Protection of Minority Security Holders in Special
Transactions ("MI 61-101"). The Company intends to rely on an
exemption from the valuation and minority shareholder approval
requirements of MI 61-101 contained in Sections 5.5(a) and
5.7(1)(a) of MI 61-101 in respect of Cranberry Capital's
investment. The exemption is based on the fact that the market
value of Cranberry Capital's investment does not exceed 25% of the
market value of the Company.
The Company also granted nine million stock options with an
exercise price of $0.35 per share
that vest over four years. The options have a duration of ten
years.
The foregoing is subject to regulatory approval by the TSX
Venture Exchange.
About Orogen Royalties
Orogen Royalties Inc. is engaged in project generation for
precious and base metal deposits in western North America with a focus on organic royalty
creation and royalty acquisitions. Orogen's royalty portfolio
includes the Ermitaño West gold deposit in Sonora, Mexico (2% NSR) being developed by
First Majestic Silver Corp. and the Silicon gold project (1% NSR)
in Nevada, USA, being advanced by
AngloGold Ashanti N.A. The Company is well financed with several
projects actively being developed by joint venture partners.
On Behalf of the Board
OROGEN ROYALTIES
INC.
Paddy Nicol
President &
CEO
Visit our website at www.orogenroyalties.com.
Orogen Royalties Inc.
1201 - 510 West Hastings Street
Vancouver, BC
Canada V6B 1L8
info@orogenroyalties.com
Forward Looking Information
This news release includes
certain statements that may be deemed "forward looking statements".
All statements in this presentation, other than statements of
historical facts, that address events or developments that Orogen
Royalties Inc. (the "Company") expect to occur, are forward looking
statements. Forward looking statements are statements that are not
historical facts and are generally, but not always, identified by
the words "expects", "plans", "anticipates", "believes", "intends",
"estimates", "projects", "potential" and similar expressions, or
that events or conditions "will", "would", "may", "could" or
"should" occur.
Forward looking information relates to statements concerning the
Company's future outlook and anticipated events or results, as well
as the Company's management expectations with respect to the
proposed business combination (the "Transaction"). This document
also contains forward-looking statements regarding the anticipated
completion of the Transaction and timing thereof. Forward-looking
statements in this document are based on certain key expectations
and assumptions made by the Company, including expectations and
assumptions concerning the receipt, in a timely manner, of
regulatory and stock exchange approvals in respect of the
Transaction.
Although the Company believe the expectations expressed in such
forward looking statements are based on reasonable assumptions,
such statements are not guarantees of future performance and actual
results may differ materially from those in the forward looking
statements. Factors that could cause the actual results to differ
materially from those in forward looking statements include market
prices, exploitation and exploration successes, and continued
availability of capital and financing, and general economic, market
or business conditions. Furthermore, the extent to which
COVID-19 may impact the Company's business will depend on future
developments such as the geographic spread of the disease, the
duration of the outbreak, travel restrictions, physical distancing,
business closures or business disruptions, and the effectiveness of
actions taken in Canada and other
countries to contain and treat the disease. Although it is not
possible to reliably estimate the length or severity of these
developments and their financial impact as of the date of approval
of these condensed interim consolidated financial statements,
continuation of the prevailing conditions could have a significant
adverse impact on the Company's financial position and results of
operations for future periods.
Investors are cautioned that any such statements are not
guarantees of future performance and actual results or developments
may differ materially from those projected in the forward looking
statements. Forward looking statements are based on the beliefs,
estimates and opinions of the Company's management on the date the
statements are made. Except as required by securities laws, the
Company undertakes no obligation to update these forward looking
statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.
SOURCE Orogen Royalties Inc.